Skip to main content
Full access
Letters to the Editor
Published Online: 1 February 2017

Familial Confounding of the Association Between Maternal Smoking During Pregnancy and Schizophrenia

To the Editor: In the August 2016 issue of the Journal, Niemelä et al. (1) reported a 38% increased odds of schizophrenia in offspring exposed to maternal smoking during pregnancy. This is problematic because smoking during pregnancy and schizophrenia are both heritable phenotypes, and recent research suggests a genetic overlap between schizophrenia and smoking, indicating that unmeasured familial confounding may explain at least part of the observed association.
We conducted a nationwide cohort study including 734,284 individuals born in Denmark between 1991 and 2002 to examine the putative effect of maternal smoking on the risk of schizophrenia using family-based designs. During the study period, 2,769 individuals were assigned a schizophrenia spectrum diagnosis (ICD-10 codes F20–F29). Information on maternal smoking reported at the first antenatal visit (13–15 weeks of gestation) was derived from the Danish Medical Birth Register (2).
At the entire population level, we observed a significantly increased risk of schizophrenia in offspring exposed to maternal smoking during pregnancy, even after adjusting for a variety of covariates (gender, calendar year, mother’s parity, parental age at childbirth, parental psychiatric history, parental highest education at time of birth, and parental income at time of birth). The hazard ratio was 1.33 and thereby highly comparable to the risk observed in the study by Niemelä et al. (1). However, after accounting for the woman’s tendency to smoke during all her pregnancies, as recommended by Begg and Parides (3), the hazard ratio was 1.21, which was markedly reduced and no longer statistically significant. Furthermore, siblings within the same family, who were differentially exposed to maternal smoking during pregnancy, did not differ in their risk to develop schizophrenia (Table 1).
TABLE 1. Maternal Smoking During Pregnancy and Risk of Schizophrenia in Offspring
 Individual Maternal Smoking During PregnancyaIndividual and Familial Maternal Smoking During PregnancybDifferentially Exposed Siblingsc
ExposureHazard Ratio95% CIHazard Ratio95% CIHazard Ratio95% CI
Individual-level effect of maternal smoking during pregnancy1.331.23–1.451.210.96–1.521.160.64–2.09
Familial-level effect of maternal smoking during pregnancy  1.401.25–1.57  
a
Hazard ratio of individual maternal smoking during pregnancy, adjusted for calendar year of birth, gender, parity, parental age at time of birth, parental income, parental education, and parental psychiatric history.
b
Hazard ratios of familial and individual maternal smoking during pregnancy, adjusted for calendar year of birth, gender, parity, parental age at time of birth, parental income, parental education, and parental psychiatric history.
c
Hazard ratio of maternal smoking during pregnancy derived from stratified Cox regression models with a separate stratum for each set of maternal siblings, adjusted for calendar year of birth, gender, parity, parental age at time of birth, parental income, parental education, and parental psychiatric history.
The Danish results strongly suggest that unmeasured genetic factors or shared familial environment are likely to account for the increased risk of schizophrenia among offspring exposed to maternal smoking. Although smoking during pregnancy is known to be harmful in many ways (e.g., low birth weight and infant mortality), and pregnant women should still be encouraged to stop smoking, maternal smoking during pregnancy seems not to be an independent risk factor for schizophrenia.

References

1.
Niemelä S, Sourander A, Surcel HM, et al: Prenatal nicotine exposure and risk of schizophrenia among offspring in a national birth cohort. Am J Psychiatry 2016; 173:799–806
2.
Knudsen LB, Olsen J: The Danish Medical Birth Registry. Dan Med Bull 1998; 45:320–323
3.
Begg MD, Parides MK: Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data. Stat Med 2003; 22:2591–2602

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 187
PubMed: 28142267

History

Accepted: October 2016
Published online: 1 February 2017
Published in print: February 01, 2017

Keywords

  1. Biological Markers
  2. Schizophrenia
  3. Epidemiology
  4. Psychoactive Substance Use Disorder

Authors

Affiliations

Sandra M. Meier, Ph.D.
From the Child and Adolescent Mental Health Center—Mental Health Services Capital Region, Copenhagen; the Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark; the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark; the Center for Integrated Register-based Research, Aarhus University, Aarhus V, Denmark; and the Department of Public Health, Section for Biostatistics, Aarhus University, Aarhus V, Denmark.
Ole Mors, Ph.D.
From the Child and Adolescent Mental Health Center—Mental Health Services Capital Region, Copenhagen; the Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark; the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark; the Center for Integrated Register-based Research, Aarhus University, Aarhus V, Denmark; and the Department of Public Health, Section for Biostatistics, Aarhus University, Aarhus V, Denmark.
Erik Parner, Ph.D.
From the Child and Adolescent Mental Health Center—Mental Health Services Capital Region, Copenhagen; the Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark; the Lundbeck Foundation Initiative for Integrative Psychiatric Research, Denmark; the Center for Integrated Register-based Research, Aarhus University, Aarhus V, Denmark; and the Department of Public Health, Section for Biostatistics, Aarhus University, Aarhus V, Denmark.

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share